aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Eli: Revolutionizing women's health with continuous, at-home hormone monitoring technology.
Eli, founded with the mission to revolutionize women's health, focuses on continuous hormone monitoring through at-home saliva tests. Their innovative technology provides personalized hormone profiles, offering real-time insights into key health areas such as menopause, fertility, contraception, and endocrine conditions. By moving beyond traditional, infrequent testing methods, Eli aims to empower women with the knowledge to manage their hormonal health more effectively and proactively.
Notable figures associated with Eli include experts in women's health and technology innovation. The company has garnered attention from prominent investors in the health tech sector. Key achievements include the development of their proprietary at-home hormone monitoring system and successful pilot programs demonstrating its efficacy. Eli's impact lies in its potential to transform women's health management by providing continuous, accessible, and personalized hormonal insights.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Hormone Monitoring
Technology
Analytics
Tags
Biotech, Healthtech
Model Types
Hardware, Software
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Eli founded?
Eli was founded in 2019.
Where is Eli’s headquarters located?
Eli’s headquarters is located in Montréal, CA.
When was Eli’s last funding round?
Eli’s most recent funding round was for $3.6M (USD) in April 2023.
How many employees does Eli have?
Eli has 15 employees as of Feb 4, 2024.
How much has Eli raised to-date?
As of July 05, 2023, Eli has raised a total of $7.1M (USD) since Apr 4, 2023.
Add Comparison
Total Raised to Date
$7.1M
USD
Last Update Apr 4, 2023
Last Deal Details
$3.6M
USD
Apr 4, 2023
Seed
Total Employees Over Time
15
As of Feb 2024
Eli Address
Montréal,
Canada
TechCrunch
Posh raises $22M to become TikTok for small events
Platforms like TikTok and Spotify have experimented with events on their platforms. But rather than concentrating on concerts and large...
Jul 23, 2024
Is this the right Eli?
Help us improve our AI - Is this article for the right company?
TechCrunch
Israel’s startup scene shows reslience despite nine months of war
When the war between Israel and Hamas broke out last October, we examined its potential impact on the tech ecosystems in Israel and...
Jul 18, 2024
Is this the right Eli?
Help us improve our AI - Is this article for the right company?
TechCrunch
How VanMoof’s new owners plan to win over its old customers
When VanMoof declared bankruptcy last year, it left around 5,000 customers who had pre-ordered e-bikes in the lurch. Now VanMoof is up and...
Jul 15, 2024
Is this the right Eli?
Help us improve our AI - Is this article for the right company?
TechCrunch
Here’s the full list of 28 US AI startups that have raised $100M or more in 2024
In the first half of 2024 alone, more than $35.5 billion was invested into AI startups globally. © 2024 TechCrunch. All rights reserved....
Jul 13, 2024
Is this the right Eli?
Help us improve our AI - Is this article for the right company?
TechCrunch
There’s always something happening to OpenAI’s board
Welcome back to another recap of Equity, TechCrunch’s flagship podcast about the business of startups. This episode is packed with deals,...
Jul 12, 2024
Is this the right Eli?
Help us improve our AI - Is this article for the right company?
TechCrunch
AI-powered Regard nabs $61M to find missed illness, boost hospital revenue
People in tech often say that data is the new oil. That phrase, coined by British mathematician Clive Humby, of course implies that data is...
Jul 11, 2024
Is this the right Eli?
Help us improve our AI - Is this article for the right company?
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts